Stay updated on Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Sign up to get notified when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.

Latest updates to the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page
- Check5 days agoChange DetectedThe page footer now shows Revision: v3.6.6, replacing v3.6.5, indicating a new site version. This is a minor metadata update and does not modify the study content or page functionality.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedA new 'Study Status' entry was added to the record history with dates 2026-08-14 and 2026-08-17, indicating updates to the study's current status. The addition enhances transparency of the trial's progression on the history page.SummaryDifference0.2%

- Check27 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5, indicating a new site build deployment. The change does not affect the study record content or user experience.SummaryDifference0.0%

- Check41 days agoChange DetectedThe latest revision adds updated Study Status and Contacts/Locations in the record history. It introduces version v3.6.4 on 2026-07-22 and supersedes the previous v3.6.3.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov interface. This change is a backend release update and does not modify the study record content or its visible data.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects a platform release update rather than any change to the study record content.SummaryDifference0.0%

Stay in the know with updates to Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.